133 related articles for article (PubMed ID: 33292646)
1. Optimising recruitment to the HAND-1 RCT feasibility study: integration of the QuinteT Recruitment Intervention (QRI).
Husbands S; Elliott D; Davis TRC; Blazeby JM; Harrison EF; Montgomery AA; Sprange K; Duley L; Karantana A; Hollingworth W; Mills N
Pilot Feasibility Stud; 2020 Nov; 6(1):173. PubMed ID: 33292646
[TBL] [Abstract][Full Text] [Related]
2. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI).
Donovan JL; Rooshenas L; Jepson M; Elliott D; Wade J; Avery K; Mills N; Wilson C; Paramasivan S; Blazeby JM
Trials; 2016 Jun; 17(1):283. PubMed ID: 27278130
[TBL] [Abstract][Full Text] [Related]
3. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment.
Donovan JL; Jepson M; Rooshenas L; Paramasivan S; Mills N; Elliott D; Wade J; Reda D; Blazeby JM; Moghanaki D; Hwang ES; Davies L
Trials; 2022 Apr; 23(1):258. PubMed ID: 35379301
[TBL] [Abstract][Full Text] [Related]
4. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
[TBL] [Abstract][Full Text] [Related]
5. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI).
Wade J; Farrar N; Realpe AX; Donovan JL; Forsyth L; Harkness KA; Hutchinson PJA; Kitchen N; Lewis SC; Loan JJM; Stephen J; Al-Shahi Salman R;
EClinicalMedicine; 2024 May; 71():102557. PubMed ID: 38813441
[TBL] [Abstract][Full Text] [Related]
6. Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study.
Paramasivan S; Rogers CA; Welbourn R; Byrne JP; Salter N; Mahon D; Noble H; Kelly J; Mazza G; Whybrow P; Andrews RC; Wilson C; Blazeby JM; Donovan JL
Int J Obes (Lond); 2017 Nov; 41(11):1654-1661. PubMed ID: 28669987
[TBL] [Abstract][Full Text] [Related]
7. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.
Elliott D; Hamdy FC; Leslie TA; Rosario D; Dudderidge T; Hindley R; Emberton M; Brewster S; Sooriakumaran P; Catto JWF; Emara A; Ahmed H; Whybrow P; le Conte S; Donovan JL
BJU Int; 2018 Dec; 122(6):970-977. PubMed ID: 29888845
[TBL] [Abstract][Full Text] [Related]
8. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
Rooshenas L; Scott LJ; Blazeby JM; Rogers CA; Tilling KM; Husbands S; Conefrey C; Mills N; Stein RC; Metcalfe C; Carr AJ; Beard DJ; Davis T; Paramasivan S; Jepson M; Avery K; Elliott D; Wilson C; Donovan JL; ; ; ; ;
J Clin Epidemiol; 2019 Feb; 106():108-120. PubMed ID: 30339938
[TBL] [Abstract][Full Text] [Related]
9. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
[TBL] [Abstract][Full Text] [Related]
10. A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - Quanti-Qualitative Appointment Timing.
Paramasivan S; Strong S; Wilson C; Campbell B; Blazeby JM; Donovan JL
Trials; 2015 Mar; 16():88. PubMed ID: 25873096
[TBL] [Abstract][Full Text] [Related]
11. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
Lorenc A; Rooshenas L; Conefrey C; Wade J; Farrar N; Mills N; Paramasivan S; Realpe A; Jepson M
Trials; 2023 Jun; 24(1):424. PubMed ID: 37349850
[TBL] [Abstract][Full Text] [Related]
12. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).
Paramasivan S; Huddart R; Hall E; Lewis R; Birtle A; Donovan JL
Trials; 2011 Mar; 12():78. PubMed ID: 21406089
[TBL] [Abstract][Full Text] [Related]
13. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.
Conefrey C; Donovan JL; Stein RC; Paramasivan S; Marshall A; Bartlett J; Cameron D; Campbell A; Dunn J; Earl H; Hall P; Harmer V; Hughes-Davies L; Macpherson I; Makris A; Morgan A; Pinder S; Poole C; Rea D; Rooshenas L;
Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):382-389. PubMed ID: 32089356
[TBL] [Abstract][Full Text] [Related]
15. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials.
Donovan JL; Paramasivan S; de Salis I; Toerien M
Trials; 2014 Jan; 15():5. PubMed ID: 24393291
[TBL] [Abstract][Full Text] [Related]
16. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
Rooshenas L; Elliott D; Wade J; Jepson M; Paramasivan S; Strong S; Wilson C; Beard D; Blazeby JM; Birtle A; Halliday A; Rogers CA; Stein R; Donovan JL; ; ; ; ; ;
PLoS Med; 2016 Oct; 13(10):e1002147. PubMed ID: 27755555
[TBL] [Abstract][Full Text] [Related]
17. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
[TBL] [Abstract][Full Text] [Related]
18. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study.
McDermott C; Vennik J; Philpott C; le Conte S; Thomas M; Eyles C; Little P; Blackshaw H; Schilder A; Hopkins C
Trials; 2021 Jan; 22(1):54. PubMed ID: 33436031
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.
Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T
Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903
[TBL] [Abstract][Full Text] [Related]
20. Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure.
Wade J; Humphrys E; Realpe AX; Gaunt DM; Burt J;
Trials; 2023 May; 24(1):305. PubMed ID: 37131255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
